ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and migration.

Mol Oncol · 2024 · PMC11161730 · PMID 38375974

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

not yet significantno p-value reported

In the relatively small Aachen patient cohort, a tendency towards ITIH5 loss in the metastases ( n = 19) was already detectable, but this was not yet significant.

also in 316 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.